Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?

Neuromuscul Disord. 2005 Jun;15(6):399-402. doi: 10.1016/j.nmd.2005.03.003. Epub 2005 Apr 18.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Genetic Therapy / methods*
  • Humans
  • Muscular Dystrophy, Duchenne / therapy*
  • Oligonucleotides, Antisense / therapeutic use*

Substances

  • Oligonucleotides, Antisense